Radyx Pharma Tech ApS

CVR 45756726 · Private limited company (ApS) · Active · Medium risk

Radyx Pharma Tech ApS is a Private limited company (ApS), founded on , based in Beder. The company is registered in the industry computerkonsulentbistand og forvaltning af computerfaciliteter. Our model estimates a bankruptcy risk of 1.8% over the next 12 months, which is 1.3 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 94k and a net result of DKK -5,678. CEO: Lasse Meldgaard.

Bankruptcy risk for Radyx Pharma Tech ApS

1.8%
probability of bankruptcy within 12 months
Medium risk

1.3 × the average (1.41%) · higher risk than 81% of active Danish companies

Lowest riskHighest risk

Increases the risk

Age (years)1 yrs · bankruptcy rate 21.6%2.5×
Published annual reports1 · bankruptcy rate 18.7%2.1×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Registered owners4+ · bankruptcy rate 5.7%0.65×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Has a boardYes · bankruptcy rate 6.0%0.68×
Return on assets-20%–0% · bankruptcy rate 6.2%0.70×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
45756726
Status
Active
Company type
Private limited company (ApS)
Founded
(1 years)
Address
Fuldenvej 71
8330 Beder
Municipality
Aarhus
Industry
Computerkonsulentbistand og forvaltning af computerfaciliteter (622000)
Bankruptcies in the industry: Konsulentbistand vedrørende informationsteknologi
Share capital
DKK 100k
Auditor
Seiersen Revision I/S
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 1
Missing annual reportNo
Negative equityNo
Equity ratio100.0%
Current ratio–
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address6
Going-concern uncertaintyNo

Financials and key figures

Financial year2025
Gross profitDKK -4,673
Net profitDKK -5,678
EquityDKK 94k
Total assetsDKK 94k
CashDKK 93k
Avg. employees0

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Seiersen Revision I/S.

Filed annual reports

Reporting periodPublishedDays after period end
1 Aug 2025 – 31 Dec 2025180

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOLasse MeldgaardCurrent
BoardJakob Juul RasmussenCurrent
BoardThomas BakCurrent
BoardTrine Stougaard BakCurrent
BoardMikkel WalmarCurrent
Owner (15%)TH BAK HOLDING ApSCurrent
Owner (33%)CACAO ApSCurrent
Owner (10%)26c Holding ApSCurrent
Owner (20%)JaJR Holding 2 ApSCurrent
Owner (15%)TS Bak Holding ApsCurrent
FounderTH BAK HOLDING ApSCurrent
FounderCACAO ApSCurrent
Founder26c Holding ApSCurrent
FounderJaJR Holding 2 ApSCurrent
FounderTS Bak Holding ApsCurrent

The CEOs' other companies

Lasse Meldgaard – 4 other companies, of which 1 bankrupt

Address history (0 moves)

Fuldenvej 71, 8330 Beder

Other companies at the same address

Similar companies in Aarhus

Questions and answers about Radyx Pharma Tech ApS

Has Radyx Pharma Tech ApS gone bankrupt?

No, Radyx Pharma Tech ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Radyx Pharma Tech ApS?

Our model estimates a bankruptcy risk of 1.8% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.

Who is the CEO of Radyx Pharma Tech ApS?

Lasse Meldgaard is the CEO of Radyx Pharma Tech ApS.

Who is the auditor of Radyx Pharma Tech ApS?

Radyx Pharma Tech ApS most recently used Seiersen Revision I/S.

When was Radyx Pharma Tech ApS founded?

Radyx Pharma Tech ApS was founded on 16 July 2025.

What is the equity of Radyx Pharma Tech ApS?

Equity was DKK 94k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.